For Imugene? Currently the only active trials with sites recruiting in Australia are Azer-cel and Vaxinia. Australian sites are planned for onCARlytics and the PD1-Vaxx trial for CRC.
Of the completed trials, only NextHerizon (HER-Vaxx) and Imprinter (PD1-Vaxx) had Australian sites (amongst other locations).
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
-0.025(6.85%) |
Mkt cap ! $73.60M | |||
| Open | High | Low | Value | Volume |
| 35.5¢ | 35.5¢ | 33.5¢ | $593.4K | 1.708M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 236991 | 33.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 15666 | 5 |
View Market Depth
| Last trade - 13.43pm 22/07/2025 (20 minute delay) ? |
| IMU (ASX) Chart |